EGFR-targeted antibody-toxin conjugate in recurrent glioma: a phase 1 trial. (nature.com)

Authors: Chandramohan V … Desjardins A Journal: Nature Medicine Published: 2026-10-16 DOI: https://doi.org/10.1038/s41591-026-04715-w